Haptoglobin Genotype and Its Role in Diabetic Cardiovascular Disease
Authors:
- 24 March 2012
- journal article
- review article
- Published by Springer Nature in Journal of Cardiovascular Translational Research
- Vol. 5 (4) , 423-435
Abstract
Over the past decade, several longitudinal epidemiological studies have brought attention to the haptoglobin genotype and its importance in determining diabetic vascular disease risk. This manuscript presents an overview of the biology of the haptoglobin genotype and reviews the literature concerning its role in the development of cardiovascular disease among individuals with diabetes mellitus.Keywords
This publication has 109 references indexed in Scilit:
- Vitamin E therapy results in a reduction in HDL function in individuals with diabetes and the haptoglobin 2-1 genotypeAtherosclerosis, 2011
- High-density lipoprotein cholesterol in diabetes: Is higher always better?Journal of Clinical Lipidology, 2011
- Is Diabetic Retinopathy Related to Subclinical Cardiovascular Disease?Ophthalmology, 2011
- The effect of vitamin E supplementation on cardiovascular risk in diabetic individuals with different haptoglobin phenotypesAtherosclerosis, 2010
- The haptoglobin 2–2 genotype is associated with increased redox active hemoglobin derived iron in the atherosclerotic plaqueAtherosclerosis, 2010
- Inflammation in AtherosclerosisJACC, 2009
- Vitamins E and C in the Prevention of Prostate and Total Cancer in MenJAMA, 2009
- Rate of nitric oxide scavenging by hemoglobin bound to haptoglobinNitric Oxide, 2008
- Hemoglobin and Overt Nephropathy Complications in Type 1 DiabetesAnnals of Epidemiology, 2008
- A Randomized Factorial Trial of Vitamins C and E and Beta Carotene in the Secondary Prevention of Cardiovascular Events in WomenArchives of internal medicine (1960), 2007